Related Experiment Video

Updated: Aug 4, 2026

Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos
11:20

Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos

Published on: May 12, 2020

Treatment of Pseudomonas meningitis with ceftazidime with or without concurrent therapy

W J Rodriguez1, W N Khan, D M Cocchetto

  • 1Children's Hospital National Medical Center, Washington, DC 20010.

The Pediatric Infectious Disease Journal
|February 1, 1990
PubMed

Insights

Ceftazidime effectively treated pediatric bacterial meningitis caused by Pseudomonas species. This antibiotic demonstrated significant clinical and bacteriological cure rates, offering a valuable therapeutic option.

Area of Science:

  • Infectious Diseases
  • Pediatric Medicine
  • Pharmacology

Background:

  • Bacterial meningitis in children poses significant health risks.
  • Pseudomonas species are a notable cause of bacterial meningitis.
  • Previous treatments for Pseudomonas meningitis have limitations.

Purpose of the Study:

  • To evaluate the efficacy and safety of ceftazidime in treating pediatric bacterial meningitis caused by Pseudomonas species.
  • To assess treatment outcomes, including clinical and bacteriological cure rates.
  • To determine the duration and dosage of ceftazidime required for effective treatment.

Main Methods:

  • A study involving 10 pediatric patients with Pseudomonas meningitis across Europe and the United States.
  • Patients received ceftazidime treatment for 10 to 42 days at dosages of 109 to 300 mg/kg/day.
  • Analysis of clinical outcomes, bacteriological eradication, and cerebrospinal fluid sterilization.

Main Results:

  • Seven of 10 patients achieved clinical cure; 3 patients died.
  • Nine of 10 patients were bacteriologically cured.
  • Cerebrospinal fluid sterilization occurred within 48 hours to 12 days.
  • Most patients had prior antimicrobial treatments, including aminoglycosides.

Conclusions:

  • Ceftazidime demonstrates utility in treating pediatric bacterial meningitis caused by Pseudomonas species.
  • The antibiotic achieved high rates of clinical and bacteriological cure.
  • Further investigation into ceftazidime's role in managing Pseudomonas meningitis is warranted.

More Related Videos

Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis07:16

Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis

Published on: September 20, 2024

Modeling Persistent Pseudomonas aeruginosa Infection in Wounded Zebrafish Larvae06:04

Modeling Persistent Pseudomonas aeruginosa Infection in Wounded Zebrafish Larvae

Published on: June 13, 2025

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...